ACC.26 advanced registration ends Feb. 12 – register now!

Thorsten Leucker, MD, PhD, FACC

General Statement of Disclosure:

RESEARCH/RESEARCH GRANTS: Merck & Co., Inc.(SIGNIFICANT), Novartis Corporation(SIGNIFICANT)

View Full Disclosure